Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-08-15

Clinical Trial Update: An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes

View source ↗

Summary

Observational study update on the efficacy and safety of Levemir (insulin detemir) in people with insulin-dependent type 1 or type 2 diabetes; the trial is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED